Clinical Trial Update: A Study to Evaluate Neoadjuvant Sonidegib Followed by Surgery or Imiquimod in the Management of Basal Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating neoadjuvant sonidegib followed by surgery or imiquimod in basal cell carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma

Drugs mentioned

• Imiquimod (imiquimod)
• Sonidegib (Odomzo) (sonidegib)

Snippet

Sponsor: Melanoma Institute Australia | Conditions: Basal Cell Carcinoma, Basal Cell Carcinoma of Skin, Site Unspecified | Phase 2 | Status: COMPLETED